MINNEAPOLIS, July 9, 2012 (GLOBE NEWSWIRE) -- Vascular Solutions, Inc. (Nasdaq:VASC) today announced that it has launched its Gel-Block embolization pledgets in the United States for use in the treatment of hypervascular tumors and arteriovenous malformations (AVMs). The company believes its new Gel-Block product represents a major improvement in the precision of sizing, consistency of delivery, and ease-of-use over current embolization practice.
